(5-phenylpyridin-3-yl)methanamine dihydrochloride, 95.0%, 1g

DIMETHYL 4-PHENOXYPYRIDINE-2,6-DICARBOXYLATE, 95.0%, 500mg

(2E)-3-(4-bromophenyl)-1-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(3-(phenoxymethyl)-1,2,4-oxadiazol-5-yl)methanamine hydrochloride, 95.0%, 500mg

1-(tert-Butyl) 3-ethyl 4-amino-5,6-dihydropyridine-1,3(2H)-dicarboxylate, 97%, 10g

5,7-Difluoro-1-benzofuran-3-carboxylic acid, 95%, 2.5g

2-Benzoxazol-2-yl-1-(3-trifluoromethylphenyl)ethanol, 97.0%, 5g

trans-4-[[[[(9H-Fluoren-9-yl)methoxy]carbonyl]amino]methyl]cyclohexanecarboxylic Acid>98.0%(HPLC)(T)1g

Isobutyl Tiglate (stabilized with HQ)>96.0%(GC)25mL

tert-Butyl (3aS,7aS)-octahydro-6H-pyrrolo[2,3-c]pyridine-6-carboxylate, 98%, 250mg

tert-Butyl 1-oxa-6-azaspiro[3.3]heptane-6-carboxylate, 97%, 5g

4-[4-(1,1-Dimethylethyl)phenyl]-1H-pyrazole, 500mg

2-(3',3'-Dimethyl-6-nitrospiro[chromene-2,2'-indolin]-1'-yl)ethyl methacrylate, 97.0%, 100mg